Trivadi S Ganesan


Ontology type: schema:Person     


Person Info

NAME

Trivadi S

SURNAME

Ganesan

Publications in SciGraph latest 50 shown

  • 2019-04 Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single Centre in INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
  • 2019-01 Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era in INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
  • 2019-01 Outcomes of Oral Metronomic Therapy in Patients with Lymphomas in INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
  • 2018-10 Efficacy of Single Dose Rasburicase (1.5 mg) for Prophylaxis and Management of Laboratory Tumor Lysis Syndrome in INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
  • 2018-07 DA-EPOCH-R in Aggressive CD 20 Positive B Cell Lymphomas: Real-World Experience in INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
  • 2018-07 Acute Lymphoblastic Leukemia in Young Adults Treated with Intensive “Pediatric” Type Protocol in INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
  • 2018-07 Experience with the Use of Nilotinib in Indian Patients in INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
  • 2018-01 Effectiveness of olanzapine in patients who fail therapy with aprepitant while receiving highly emetogenic chemotherapy in MEDICAL ONCOLOGY
  • 2017-12 Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin in SCIENTIFIC REPORTS
  • 2017-12 Predictors of Chemotherapy Related Toxicities in Elderly Lymphoma Patients: Experience from a Tertiary Cancer Centre in INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
  • 2017-11 Therapeutic antibodies against cancer stem cells: a promising approach in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2017-02 Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2016-09 Acute Myeloid Leukemia in Children: Experience from Tertiary Cancer Centre in India in INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
  • 2011-03 The tumor suppressor RASSF1A is a novel effector of small G protein Rap1A in PROTEIN & CELL
  • 2010-04 A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer in BRITISH JOURNAL OF CANCER
  • 2007-02 RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer in ONCOGENE
  • 2007 Intraperitoneal Gene Therapy in PERITONEAL CARCINOMATOSIS
  • 2007 Tyrosine Kinase Inhibitors and Cancer Therapy in TARGETED INTERFERENCE WITH SIGNAL TRANSDUCTION EVENTS
  • 2006-06 Role of lymphangiogenesis in epithelial ovarian cancer in BRITISH JOURNAL OF CANCER
  • 2005-07 Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer in BRITISH JOURNAL OF CANCER
  • 2004-11 Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma in BRITISH JOURNAL OF CANCER
  • 2004-07 Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer in BRITISH JOURNAL OF CANCER
  • 2003-10 Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents in BRITISH JOURNAL OF CANCER
  • 2003-09 A phase 1 study of tazarotene in adults with advanced cancer in BRITISH JOURNAL OF CANCER
  • 2002-12 The human homologue of unc-93 maps to chromosome 6q27 – characterisation and analysis in sporadic epithelial ovarian cancer in BMC GENETICS
  • 2002-01 Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer in ONCOGENE
  • 2000-07 Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha in BRITISH JOURNAL OF CANCER
  • 2000-06 Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2000 Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2000 Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine in BRITISH JOURNAL OF CANCER
  • 1998-12 Chemotherapy for ovarian cancer - a consensus statement on standard practice in BRITISH JOURNAL OF CANCER
  • 1998-11 A phase II study of bryostatin 1 in metastatic malignant melanoma in BRITISH JOURNAL OF CANCER
  • 1998-06 Phase I study of the mitomycin C analogue BMS-181174 in BRITISH JOURNAL OF CANCER
  • 1998-06 Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer in BRITISH JOURNAL OF CANCER
  • 1997-06 Molecular approaches to diagnosis and management of ovarian cancer in CANCER AND METASTASIS REVIEWS
  • 1996-03 H-RYK, an Unusual Receptor Kinase: Isolation and Analysis of Expression in Ovarian Cancer in MOLECULAR MEDICINE
  • 1996-02 An integrated genetic map of Chromosome 6 in MAMMALIAN GENOME
  • 1995-09 The genetic analysis of ovarian cancer in BRITISH JOURNAL OF CANCER
  • 1995-05 Inhibin as a marker for ovarian cancer in BRITISH JOURNAL OF CANCER
  • 1995-01 Association Between HLA DQBl * 03 and Cervical Intra-epithelial Neoplasia in MOLECULAR MEDICINE
  • 1993-10 Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma in BRITISH JOURNAL OF CANCER
  • 1992-03 Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years in BRITISH JOURNAL OF CANCER
  • 1990-08 Radiotherapy for stage I Hodgkin's disease: 20 years experience at St Bartholomew's Hospital in BRITISH JOURNAL OF CANCER
  • 1987-10 Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia in NATURE
  • 1987-04 A phase II study of high-dose cytosine arabinoside in the treatment of acute leukaemia in adults in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1987-04 Angio-immunoblastic lymphadenopathy: A clinical, immunological and molecular study in BRITISH JOURNAL OF CANCER
  • 1987 Rearrangement of the bcr Gene in Philadelphia-Chromosome-Negative Chronic Myeloid Leukemia in MODERN TRENDS IN HUMAN LEUKEMIA VII
  • 1986-09 EVA treatment for recurrent or unresponsive Hodgkin's disease in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1985 The Feasibility of Opal/High Dose Ara-C Treatment of Adult Acute Lymphoblastic Leukaemia in MODERN TRENDS IN HUMAN LEUKEMIA VI NEW RESULTS IN CLINICAL AND BIOLOGICAL RESEARCH INCLUDING PEDIATRIC ONCOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.418600.b", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4868.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.427788.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4991.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415719.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.8348.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.421962.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413842.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416353.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7445.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4305.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411370.0", 
            "type": "Organization"
          }
        ], 
        "familyName": "Ganesan", 
        "givenName": "Trivadi S", 
        "id": "sg:person.01354150255.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354150255.82"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:48", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_541.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01354150255.82'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01354150255.82'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01354150255.82'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01354150255.82'


     

    This table displays all metadata directly associated to this object as RDF triples.

    38 TRIPLES      10 PREDICATES      22 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01354150255.82 schema:affiliation Nd2e2d6977ca04762ada6d50b9e8bc499
    2 https://www.grid.ac/institutes/grid.411370.0
    3 https://www.grid.ac/institutes/grid.413842.8
    4 https://www.grid.ac/institutes/grid.415719.f
    5 https://www.grid.ac/institutes/grid.416353.6
    6 https://www.grid.ac/institutes/grid.421962.a
    7 https://www.grid.ac/institutes/grid.427788.6
    8 https://www.grid.ac/institutes/grid.4305.2
    9 https://www.grid.ac/institutes/grid.4868.2
    10 https://www.grid.ac/institutes/grid.4991.5
    11 https://www.grid.ac/institutes/grid.7445.2
    12 https://www.grid.ac/institutes/grid.8348.7
    13 schema:familyName Ganesan
    14 schema:givenName Trivadi S
    15 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354150255.82
    16 schema:sdDatePublished 2019-03-07T14:48
    17 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    18 schema:sdPublisher Ne89e76262db241229fa5d1f4df56f4b2
    19 sgo:license sg:explorer/license/
    20 sgo:sdDataset persons
    21 rdf:type schema:Person
    22 Nd2e2d6977ca04762ada6d50b9e8bc499 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
    23 sgo:isCurrent true
    24 rdf:type schema:OrganizationRole
    25 Ne89e76262db241229fa5d1f4df56f4b2 schema:name Springer Nature - SN SciGraph project
    26 rdf:type schema:Organization
    27 https://www.grid.ac/institutes/grid.411370.0 schema:Organization
    28 https://www.grid.ac/institutes/grid.413842.8 schema:Organization
    29 https://www.grid.ac/institutes/grid.415719.f schema:Organization
    30 https://www.grid.ac/institutes/grid.416353.6 schema:Organization
    31 https://www.grid.ac/institutes/grid.418600.b schema:Organization
    32 https://www.grid.ac/institutes/grid.421962.a schema:Organization
    33 https://www.grid.ac/institutes/grid.427788.6 schema:Organization
    34 https://www.grid.ac/institutes/grid.4305.2 schema:Organization
    35 https://www.grid.ac/institutes/grid.4868.2 schema:Organization
    36 https://www.grid.ac/institutes/grid.4991.5 schema:Organization
    37 https://www.grid.ac/institutes/grid.7445.2 schema:Organization
    38 https://www.grid.ac/institutes/grid.8348.7 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...